The burden and management of febrile neutropenia vary significantly across global healthcare systems. Differences in hospital infrastructure, oncology capacity, medication accessibility, and government reimbursement structures influence how patients receive care. These variations shape the Febrile Neutropenia Market region outlook, particularly in developing versus developed regions. In...